OGN vs PIPR · P/E 3.4, rev $3.02B vs P/E 26, rev $971.4M
Organon & Co (OGN) versus Piper Sandler Companies (PIPR) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Piper Sandler Companies (PIPR) is a capital markets company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported PIPR revenue for 2026-06-30 was $971.4M. Net income was $133.1M. PIPR currently screens at market cap $4.82B and trailing P/E 25.6.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. PIPR currently screens at market cap $4.82B and trailing P/E 25.6.
Not investment advice. Open the OGN and PIPR stock pages for the full models.
Not investment advice.